Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples